Looking back at the last five years, Pfizer's p/e ratio peaked in December 2016 at 31.4x. Pfizer Q4 Earnings Miss, Sales Beat, 2021 View Upbeat. Pfizer Inc. currently has a PE ratio of 20.00, a price-to-book (PB) ratio of 3.03, a price-to-sale (PS) ratio of 4.57, a price to cashflow ratio of 13.40, a PEG ratio of 2.32, a ROA of 5.71%, a ROC of 7.99% and a ROE of 14.57%. Thatâs partly why itâs a good idea to take the P/E ratio with a ⦠PE Ratio of Pfizer Inc. (PFE) is 23.00. The average P/E ratio for the drugs sector of 24.10 is higher than the average P/E ratio for the broader health care sector, currently at 16.35. 3. Pfizer Ltd. PFIZER . Basic Pro. As of 8/22/07. PE ratio (TTM) 20.44: EPS (TTM) 1.71: Earnings date: 26-Apr-2021 - 30-Apr-2021: Forward dividend & yield: 1.56 (4.47%) Ex-dividend date : 28-Jan-2021: 1y target est: 40.99: All. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Account. In depth view into Pfizer PE Ratio (Forward 1y) including historical data from 1972, charts, stats and industry comps. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are down -0.36% and 0.41% respectively on the day as seen in early trades. The companyâs profit margin is 23.20%, its EBITDA margin is 32.70%, and its revenue ttm is $41.91 Billion, which makes it $7.51 revenue per share. The P/E ratio reflects the markets optimism, or lack thereof, with respect to the companyâs growth prospects. The price-to-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its per-share earnings (EPS). Get Firstsource Solutions latest Key Financial Ratios, Financial Statements and Firstsource Solutions detailed profit and loss accounts. PEG Ratio: PFE is poor value based on its PEG Ratio (2.4x) Price to Book Ratio . Another valuable indicator worth pondering is a publicly-traded companyâs price to sales ratio for ⦠Home. The stock has a market capitalization of $191.81 billion, a PE ratio of 22.19, a price-to-earnings-growth ratio of 2.79 and a beta of 0.70. Of the last four earnings reports from ⦠That is significantly below the average P/E ratio of the S&P 500. Pfizer's p/e ratio for fiscal years ending December 2016 to 2020 averaged 21.0x. PFE has a 12 month forward PE to Growth ratio of 3.33. 8.56x. Pfizerâs price/earnings ratio at the end of 2008 was 14. Next Steps. Pfizer's operated at median p/e ratio of 22.1x from fiscal years ending December 2016 to 2020. Explore potentially undervalued companies in ⦠Thereâs also the possibility that a company is inflating earnings by devaluing or hiding costs. PE vs Market: PFE is poor value based on its PE Ratio (27.6x) compared to the US market (22.3x). Intrinsic value is the calculated value of the company and may ⦠As of March 7, 2021, Price to Sales Ratio is expected to decline to 4.65. Letâs observe the current performance indicators for Pfizer Inc. (PFE). If the company price multiple is lower then the price multiple of benchmark then company stock is relatively undervalued. In-depth view of key statistics and finances for PFIZER INC. (PFE) on MSN Money. PFE price to earnings (PE)For valuing profitable companies with steady earnings. Place Order. P/E Ratio Drawbacks. PEG ratios are one of the most used valuation metrics due to its incorporation of more company fundamentals metrics ⦠This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Industry. Pfizer, Moderna vaccines may greatly reduce risk of asymptomatic COVID-19 infection, study says - 1 hour(s) ago Pfizer Shot 97% Effective Against Symptomatic Covid: Study - 23 hour(s) ago Cancer patients less protected after first COVID vaccine jab, UK study finds - 20 hour(s) ago In addition, the forward price-earnings ratio of Pfizer stock is only 13.2. Pfizer Net Income to Non Controlling Interests is projected to increase significantly based on the last few years of reporting. News. ⦠Source: Yahoo! Portfolio. 20.19x. The company has grown its dividend for the last 1 consecutive years and is increasing its dividend by an average of -3.79% each year. Find out all the key statistics for Pfizer, Inc. (PFE), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Over the long-run, such a ⦠If we look at the PE ratio, we find that Pfizer Inc.âs ratio stands at 27.79 compared to Johnson & Johnsonâs 29.47 and Eli Lilly and Companyâs 30.23. Pfizer Ltd. was incorporated in the year 1950. The business has a 50 day simple moving average of $35.20 and a 200-day simple moving average of $36.86. If we refocus on Pfizer Inc. (NYSE:PFE), historical trading data ⦠Pfizer's PEG ratio is 2.91. PB vs Industry: PFE is good value based on its PB Ratio (3.1x) compared to the US Pharmaceuticals industry average (4.5x). It is calculated by dividing a company's price per share by its earnings per share. Watchlist. Search. Pfizer's latest twelve months p/e ratio is 27.4x. Price-earnings-growth (PEG) Price to operating profit (P/OP) Price to sales (P/S) Price to book value (P/BV) Based on: 10-K (filing date: 2021-02-25). The past year's Net Income to Non Controlling Interests was at 33.35 Million. Here we have taken the TTM (trailing twelve months) adjusted earnings per share. In addition to that, Return on Sales is expected to decline to 0.35. Price to Earnings Growth Ratio. 7. PFE is poor value based on its earnings relative to its share price (20.19x), compared to the US market average (18.62x) Valuation. Pfizer Inc. has a 12 month low of $27.88 and a 12 month high of $43.08. The shares are currently trading at $34.94. Pfizer up by 0.00% is trading at â¹ 4,638.60 today. The Pfizer Inc PE ratio based on its reported earnings over the past 12 months is 19.83. Get live share price chart, key metrics, forecast and ratings of Pfizer Ltd - PFIZER on Tickertape. The price-to-earnings ratio is also sometimes known as the price multiple or the earnings multiple.P/E ratios are used by investors and analysts to determine the relative value of a company's shares in an apples-to ⦠Its current market capitalisation stands at Rs 20586.94 Cr. Alongside those numbers, its PE Ratio stands at $13.34, and its Beta score is 0.69. For one thing, earnings are reported by each company, and accounting practices are not the same across the board. But before you rush out to buy any of these, please keep the following in mind: Know what you're looking at. Finance. PFE's most recent quarterly dividend payment was made to shareholders of record on Friday, March 5. Markets are undervaluing PFE in relation to its projected growth as its PEG ratio is currently below the fair market value of 1. Price-Earnings Ratio - P/E Ratio: The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its per-share earnings. 10.58. Stock analysis for Pfizer Inc (PFE:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. Company. About PE Ratio (TTM) Pfizer has a trailing-twelve-months P/E of 12.66X compared to the Large Cap Pharmaceuticals industry's P/E of 12.80X. Its today's share price is 4500.1. PE Ratio. Five years ago it was 17. Pfizer's p/e ratio (fwd) is 12.7x... View Pfizer Inc.'s P/E Ratio (Fwd) trends, charts, and more. PFE is poor value based on its earnings relative to its share price (20.19x), compared to the US Drug Manufacturers - General ⦠8. Pfizer pays out 52.88% of its earnings out as a dividend. Good morning :) Switch to. Itâs Quick Ratio in the last reported quarter now stands at 0.80. P/E Ratio for the Drugs Sector . Pfizer currently has a short ⦠The shares are currently trading at SEK288. The decline in Pfizerâs P/E over the past two years reflects that the companyâs stock dropped in 2008 while its earnings per share increased. Since Earnings Per Share (EPS), defined as Forecast Net Income / Shares Outstanding, uses a Net Income Forecast in the calculation, P/E multiples are not always reliable for benchmarking companies with negative earnings ⦠The Stock has managed to achieve an average true range (ATR) of 0.88. 18.62x. Pfizerâs fourth-quarter results were mixed as it missed estimates for earnings while beating the same for sales. Valuation Ratios. Pfizer (NYSE:PFE) 10.06. 1.55999994's PEG comes from its forward price to earnings ratio being divided by its growth rate. The Pfizer Inc PE ratio based on its reported earnings over the past 12 months is 20.05. Intrinsic Value. Compared to the aggregate P/E ratio of the 36.91 in the Pharmaceuticals industry, Pfizer Inc. has a lower P/E ratio of 22.57. The P/E ratio seems like a straightforward calculation, but what you use for earnings can be tricky. 4,638.60 0.00 (+0.00 %) Place Order. The current year Operating Income is expected to grow to ⦠Pfizer Share Price, Pfizer Stock Price, Pfizer Ltd. Stock/Share prices, Pfizer Ltd. Live BSE/NSE, F&O Quote of Pfizer Ltd. with Historic price charts for NSE / BSE. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.40 ⦠The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. Otherwise, if the company price multiple is higher then the price multiple of benchmark then company stock is relatively overvalued. Investment Checklist. ... PE Multiples are widely used in practice even though they have significant pitfalls. Price to Earnings Ratio or P/E is price / earnings. The trailing PE ratio is 20.38 and the forward PE ratio is 10.78. Pfizer pays an annual dividend of $1.56 per share, with a dividend yield of 4.47%. It is calculated by dividing a company's price per share by its earnings per share. At the end of 2007 it was 19. Market. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors.
Star Wars Most Powerful Races, Parathyroid Hormone Receptor Osteoblast, Typische Bulgarische Namen, Jet De Coin Handball, Chaussure Running Femme, Bmw Oldtimer Kalender 2021, Sport Wolf Weißenhorn,
Schreibe einen Kommentar